Product Information

NYLIA 1-35 28 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2063 per EA under NDC 65862089888. Its NADAC has been published 223 times since Mar 23, 2022.

NYLIA 1-35 28 TABLET

Norethindrone and Ethinyl Estradiol
$0.2063per EA

NDC

65862089888

Classification

Generic

Dosage Form

KIT

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207056

On Market Since

10/21/2016

Price Statistics

The NADAC for NYLIA 1-35 28 TABLET has been published 223 times since Mar 23, 2022, and over the history we have for it it has declined 39.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2063 per EA
All-time high$0.3717 (Jul 13, 2022)
All-time low$0.1935 (May 22, 2024)
52-week high$0.2458
52-week low$0.1981
Median price$0.2723
Average price$0.2674
Largest weekly change+39.2% (Jun 19, 2024)
Weeks tracked223
Tracking sinceMar 23, 2022

Price History

1W

0.0%

1M

+0.6%

3M

+1.4%

6M

-7.0%

1Y

-16.1%

3Y

-21.7%

5Y

N/A

All

-39.8%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NYLIA 1-35 28 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NYLIA 1-35 28 TABLET, manufactured by Aurobindo Pharma Limited, is $0.2063 per EA (NDC 65862089888), effective Jun 24, 2026.

How has the price of NYLIA 1-35 28 TABLET changed over time?

Over the history we have for it, the NADAC for NYLIA 1-35 28 TABLET has declined 39.8%. It has been tracked across 223 weekly CMS publications since Mar 23, 2022.

What are the highest and lowest recorded NADAC prices for NYLIA 1-35 28 TABLET?

Since Mar 23, 2022, the NADAC for NYLIA 1-35 28 TABLET has ranged from a low of $0.1935 (May 22, 2024) to a high of $0.3717 (Jul 13, 2022), with a median of $0.2723 per EA.

Are there cheaper alternatives to NYLIA 1-35 28 TABLET?

4 NADAC-published products share the same active ingredient, strength, and dosage form as NYLIA 1-35 28 TABLET, but none are currently priced below it.

Who manufactures NYLIA 1-35 28 TABLET?

NYLIA 1-35 28 TABLET (NDC 65862089888) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.